Randomized double‐blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy

Abstract

As there are few differences between the two treatments in efficacy, lamotrigine 25 mg twice daily might be the first choice as it is associated with fewer adverse effects in our population.